Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Takeda Pharma A/S

02 1Takeda Pharma Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Brentuximab Vedotin

Brand Name : Adcetris

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 50mg

Packaging :

Approval Date : 25/10/2012

Application Number : 20110707000020

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Brentuximabum Vedotinum

Brand Name : Adcetris

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 50mg

Packaging :

Approval Date : 04/03/2013

Application Number : 62132

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Brentuximab Vedotina

Brand Name : Adcetris

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 2012-11-29

Application Number : 112794001

Regulatory Info : Authorized

Registration Country : Spain

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Brentuximab Vedotina

Brand Name : Adcetris

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 2021-01-08

Application Number : 112794001IP

Regulatory Info : Authorized

Registration Country : Spain

blank